Your Health, We Care
Release date: 2026-01-30 16:24:37 Article From: Lucius Laos Recommended: 14
Special caution is required when using anagrelide, as certain drugs may interact with it.
Do not take this medicine with cisapride, dronedarone, pimozide or thioridazine under any circumstances.
In addition, this medicine may also interact with a variety of other drugs, including aspirin and its analogs, cilostazol, dofetilide, fluvoxamine, as well as inotropic agents (e.g., milrinone, enoximone, amrinone and olprinone). Attention should also be paid to the potential risks of concomitant use with anticoagulants such as warfarin, sucralfate, theophylline and ziprasidone.
It should be noted that the above list does not cover all possible interactions. To ensure medication safety, be sure to provide your healthcare provider with a complete list of all medications you are taking, including prescription drugs, herbal medicines, over-the-counter drugs and dietary supplements. You should also inform them if you smoke, drink alcohol or use illicit drugs, as these factors may also interact with your medications.
Take the medicine to a drug take-back program location. Consult your pharmacy or law enforcement agency to find a designated site.
If drug take-back is not available, check the label or package insert to determine whether the medicine should be discarded in the trash or flushed down the toilet. If you are unsure, consult your medical team. If it is safe to discard in the trash, pour the medicine out of its container. Mix the medicine with cat litter, soil, coffee grounds or other unwanted substances. Seal the mixture in a bag or container, then place it in the garbage bin.
1. Take this medicine orally with water. Administer it at the same time each day in accordance with the instructions on the prescription label. Continue taking it unless your medical team instructs you to stop.
2. For pediatric use of this medicine, consult your medical team. Although this medicine may be prescribed for children aged 7 years and older for specific conditions, caution is still advised.
3. Overdose: If you think you have taken an overdose of this medicine, contact a poison control center or the emergency department immediately.
Note: This medicine is for your personal use only. Do not share it with others.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：802025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3732024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：712025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：932025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：872025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：1022025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：992025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：992025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
